From: Epicardial fat tissue in patients with diabetes mellitus: a systematic review and meta-analysis
Study | Country | Arms | Diabetes type | N | Age (year) | BMI (Kg/m2) | EFT | Measurement tool | NOS Score |
---|---|---|---|---|---|---|---|---|---|
Chen et al. [27] | China | Diabetes | II | 167 | 43.7 ± 10.9 | 22.6 ± 2.1 | 4.0 ± 1.5 mm | Echocardiography (end-diastole parasternal long axis) | 7 |
Non-diabetes |  | 82 | 42.4 ± 10.2 | 22.0 ± 2.1 | 2.0 ± 1.5 mm |  |  | ||
Yazici et al. [29] | Turkey | Diabetes | I | 36 | 30.8 ± 7.7 | 24.7 ± 3.8 | 3.3 ± 1.1 mm | Echocardiography (end-diastole parasternal average axis) | 7 |
Non-diabetes |  | 43 | 29.9 ± 4.9 | 24.6 ± 3.0 | 2.3 ± 0.3 mm |  |  | ||
Iacobellis et al. [20] | American | Diabetes | I | 15 | 52.8 ± 12.0 | 27.8 ± 5.2 | 7.2 ± 2.1 mm | Echocardiography (end-systole parasternal average axis) | 7 |
Non-diabetes |  | 15 | 53.0 ± 9.0 | 27.4 ± 4.1 | 4.9 ± 2.5 mm |  |  | ||
Cetin et al. [21] | Turkey | Diabetes | II | 139 | 54.3 ± 9.2 | 27.6 ± 3.1 | 6.0 ± 1.5 mm | Echocardiography (end-diastole parasternal average axis) | 7 |
Non-diabetes |  | 40 | 52.1 ± 7.3 | 29.1 ± 4.2 | 4.4 ± 1.0 mm |  |  | ||
Seker et al. [33] | Turkey | Diabetes | II | 186 | 62.5 ± 9.6 | 28.6 ± 4.4 | 6.5 ± 0.7 mm | Echocardiography (End-systole parasternal average axis) | 7 |
Non-diabetes |  | 268 | 61.2 ± 10.9 | 27.6 ± 4.2 | 5.3 ± 1.0 mm |  |  | ||
Aslan et al. [37] | Turkey | Diabetes | I | 76 | 30.6 ± 10.3 | 23.3 ± 2.7 | 3.6 ± 0.5 mm | Echocardiography (end-diastole parasternal average axis) | 7 |
Non-diabetes |  | 36 | 32.4 ± 8.5 | 24.2 ± 2.7 | 3.0 ± 0.5 mm |  |  | ||
Wang et al. [32] | China | Diabetes | II | 68 | 59.5 ± 9.9 | 26.9 ± 5.9 | 5.0 ± 1.2 mm | Echocardiography (end-diastole parasternal long axis) | 7 |
Non-diabetes |  | 32 | 58.1 ± 9.2 | 23.7 ± 5.5 | 3.1 ± 0.8 mm |  |  | ||
Vasques et al. [30] | Brazil | Diabetes | II | 31 | 45.0 ± 6.0 | 36.0 ± 4.7 | 1.0 ± 0.3 mm | Echocardiography (end-systole parasternal average axis) | 7 |
Non-diabetes |  | 37 | 36.0 ± 11.0 | 27.9 ± 7.4 | 0.7 ± 0.2 mm |  |  | ||
Wang et al. [34] | China | Diabetes | II | 49 | 56.8 ± 9.5 | 27.2 ± 3.6 | 166.1 ± 60.6 cm3 | CT | 8 |
Non-diabetes |  | 78 | 54.1 ± 6.5 | 25.4 ± 3.4 | 123.4 ± 41.8 cm3 |  |  | ||
Keles et al. [35] | Turkey | Diabetes | I | 45 | 34 ± 7.7 | 24.1 ± 3.4 | 7.0 ± 2.3 mm | Echocardiography (end-diastole parasternal long axis) | 6 |
Non-diabetes |  | 35 | 32 ± 7.3 | 26.7 ± 6.5 | 6.0 ± 1.5 mm |  |  | ||
Akbas et al. [36] | Turkey | Diabetes | II | 156 | 53.62 ± 9.33 | 31.21 ± 5.87 | 4.7 ± 1.6 mm | Echocardiography (end-diastole parasternal average axis) | 7 |
Non-diabetes |  | 50 | 51.06 ± 8.74 | 32.86 ± 7.52 | 3.9 ± 1.6 mm |  |  | ||
Akyürek et al. [31] | Turkey | Diabetes | II | 90 | 57.7 ± 11.4 | 28.9 ± 4.4 | 172.8 ± 64.9 cm3 | CT | 7 |
Non-diabetes |  | 62 | 55.6 ± 10.7 | 26.5 ± 2.9 | 68.9 ± 37.7 cm3 |  |  | ||
Philouze et al. [28] | American | Diabetes | II | 44 | 56.0 ± 6.0 | 26.9 ± 3.2 | 6.4 ± 1.7 mm | Echocardiography (end-systole parasternal average axis) | 6 |
Non-diabetes |  | 35 | 52.0 ± 7.0 | 24.2 ± 3.6 | 3.3 ± 1.1 mm |  |  |